Alexza Pharmaceuticals stands at the crossroads of innovation and advanced technology with a platform that has the potential to address unmet medical needs in neuroscience. The company required a research and development leader to oversee scientific functions and product development within the organization. Alexza retained The Chase Group (TCG) to execute a search to identify a Vice President, Research and Development. A vast network and 25+ years of experience in life sciences executive recruiting enabled TCG to secure a strong, patient-focused leader with a passion for science. The new Vice President will lead the development of an integrated portfolio of clinical and pre-clinical assets while working with Alexza to find new therapeutic solutions for conditions that would benefit from rapid, reliable, and non-invasive treatment. The Chase Group is proud to partner with Alexza to identify high caliber leaders needed to create innovative treatments providing solutions for patients and physicians. To learn more about partnering with The Chase Group to build your executive leadership team, please contact karen@chasegroup.com.
The Chase Group Successfully Completes Search for Vice President, Research & Development at Alexza Pharmaceuticals
Alexza Pharmaceuticals stands at the crossroads of innovation and advanced technology with a platform that has the potential to address unmet medical needs in neuroscience. The company required a research and development leader to oversee scientific functions and product development within the organization. Alexza retained The Chase Group (TCG) to execute a search to identify a Vice President, Research and Development. A vast network and 25+ years of experience in life sciences executive recruiting enabled TCG to secure a strong, patient-focused leader with a passion for science. The new Vice President will lead the development of an integrated portfolio of clinical and pre-clinical assets while working with Alexza to find new therapeutic solutions for conditions that would benefit from rapid, reliable, and non-invasive treatment. The Chase Group is proud to partner with Alexza to identify high caliber leaders needed to create innovative treatments providing solutions for patients and physicians. To learn more about partnering with The Chase Group to build your executive leadership team, please contact karen@chasegroup.com.- Categories: Life Sciences, Research & Development
Ionis Director, Global HEOR, Rare Disease Immunology, Successfully Placed by The Chase Group
Ami Claxton, MS, PhD has joined Ionis Pharmaceuticals, Inc. as Director, Global HEOR Rare Disease Immunology. She will play a critical and significant role as…
Successful Placement at Avidity
The Chase Group is pleased to announce the successful completion of the Vice President, Medical Affairs search for Avidity Biosciences. Nathan Weedin brings 15+ years…
The Chase Group Successfully Completes Search for Amyloidosis Medical Affairs Leader
Ionis Pharmaceuticals has a 35-year track record of perfecting and advancing RNA-targeted drug discovery and development. Projecting a vast number of new transformational products on…
The Chase Group Identifies Chief Medical Officer for Arcturus Therapeutics
In late 2022, Arcturus Therapeutics retained The Chase Group to build out additions to the leadership team. Tasked with identifying the new Chief Medical Officer,…
The Chase Group Secures VP, Head of Regulatory Affairs, for Checkmate Pharmaceuticals
The Chase Group is pleased to announce the successful recruitment of Elvis Osei Tutu, PharmD, as the Vice President, Head of Regulatory Affairs at Checkmate…
The Chase Group Secures Clinical Operations Leadership for Alexza Pharmaceuticals
The Chase Group, committed to executive recruitment in life sciences, is pleased to announce the completion of another search for Alexza Pharmaceuticals, successfully securing Mike…